Elon Musk's next target: Restoring eye sight, expects human trials in 6 months

Elon Musk's Neuralink is expecting to get USFDA approval for conducting human trials under its human eye sight restoration project. The company will begin human clinical trials in six months

from mint - Science https://ift.tt/GIHce6O
https://ift.tt/74T2zdp